COPD patients who receive intensive guidance from a hospital pharmacist during their stay use their inhalation medication ...

Women aged 40 years and older have a 50% greater risk for chronic obstructive pulmonary disease (COPD) vs men in the same age group, according to study findings published in BMJ Open Respiratory ...

While numerous studies have assessed how much people with chronic obstructive pulmonary disease (COPD) walk, few have explored how they walk, especially in unsupervised, real-life settings.

It is becoming increasingly recognized that people with COPD have an elevated risk of serious CV events,1 discussed Hanania ...

Chronic obstructive pulmonary disease (COPD) affects 25 million people in the U.S. and is the fifth leading cause of death ...

TNN Updated On Jun 16, 2025 at 02:56 PM IST ...

Three reviews ranging in quality from medium to low described a positive impact of patient or family education that focused on medication reconciliation: improved medication administration ...

One factor is exposure to carbon from smoking or breathing polluted air. “We wanted to study what happens in the lungs of COPD patients when this carbon builds up in alveolar macrophage cells, as this ...

UK-based Verona Pharma has scored a key win in a phase 3 trial of its chronic obstructive pulmonary disease (COPD) drug ensifentrine, setting up regulatory filings in the first half of next year ...

Nation’s first CME-accredited course for APPs on clinical application of diagnostic biomarkers in Lung Nodule and Lung Cancer patient programs LOUISVILLE, Colo., June 10, 2025 (GLOBE NEWSWIRE ...

Abstract and Introduction Abstract Background: The clinical trial safety database for tiotropium has been augmented with a 4-year trial in patients with COPD, which provides an opportunity to ...